Jim Simons Nano Vibronix, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $10.32 $40,745 - $977,902	-94,758 Reduced 75.27%	31,129 $14,000
Q2 2022 Aug 12, 2022	SELL	$0.55 - $1.19 $92,297 - $199,697	-167,813 Reduced 57.14%	125,887 $79,000
Q1 2022 May 13, 2022	SELL	$0.7 - $1.16 $37,634 - $62,365	-53,763 Reduced 15.47%	293,700 $341,000
Q4 2021 Feb 11, 2022	BUY	$1.0 - $2.0 $347,463 - $694,926	347,463 New	347,463 $361,000
Q3 2021 Nov 12, 2021	SELL	$0.7 - $3.37 $59,649 - $287,167	-85,213 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$0.79 - $1.15 $184,296 - $268,280	-233,287 Reduced 73.25%	85,213 $73,000
Q1 2021 May 13, 2021	SELL	$0.83 - $1.51 $161,518 - $293,846	-194,600 Reduced 37.93%	318,500 $325,000
Q4 2020 Feb 10, 2021	BUY	$0.56 - $1.13 $287,336 - $579,803	513,100 New	513,100 $392,000

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.